What conditions is leuprolide used to treat?
Leuprolide is a hormone therapy that’s used to treat conditions driven by sex hormones (especially testosterone and estrogen) by lowering signals from the brain that stimulate hormone production. Common uses include:
- Prostate cancer (advanced or metastatic), where reducing testosterone can slow tumor growth.
- Endometriosis and endometriosis-related pelvic pain, where lowering estrogen can shrink endometrial tissue activity.
- Uterine fibroids, to reduce fibroid-related bleeding and shrink fibroids before surgery.
- Central precocious puberty in children, where it helps pause early puberty by suppressing the release of puberty-triggering hormones.
How does leuprolide work in the body?
Leuprolide works by acting on the pituitary gland’s control of gonadotropins (the hormone signals that drive ovarian/testicular hormone production). With ongoing use, it decreases the body’s production of sex hormones by suppressing the gonadotropin release pathway. That hormone reduction is what makes it useful for hormone-sensitive conditions like prostate cancer, endometriosis, and fibroids.
Are there different forms, and do they change what it’s used for?
Leuprolide is available in multiple formulations and dosing schedules (for example, short-interval injections versus longer-interval depot injections). The specific form mainly affects how often it’s given, not the general types of conditions it treats. Doctors choose the formulation based on the condition, treatment duration, and practical considerations such as dosing frequency.
Who should be careful or talk to a clinician first?
Because leuprolide changes hormone levels, clinicians typically review risks related to bone density and cardiovascular/metabolic effects, especially for longer treatment courses or in patients with pre-existing issues. The exact precautions depend on the condition being treated and the patient’s health history.
What is leuprolide not used for?
Leuprolide is not a chemotherapy and is not used to treat cancers or symptoms caused by non-hormonal mechanisms. It’s specifically aimed at diseases where lowering sex-hormone signaling helps control disease activity.